openPR Logo
Press release

The Latest Techniques in HPAPI Facility Design

01-31-2019 11:39 AM CET | Health & Medicine

Press release from: SMi Group Ltd

Amongst the myriad of potential pitfalls for the Highly Potential Active Pharmaceutical Ingredients (HPAPI) industry there is a requirement for all parties involved to have a blueprint in place to ensure all containment procedures are followed correctly. Yet, there is also a need to ensure that operations are maintained at the highest standards. At SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients Conference these issues will be discussed along with design and build of a new compound, risk assessment of HPAPI products and utilisation of control matrices.

Key Sessions include:

PANEL DISCUSSION:
Control matrices, control algorithms, containment guides and confidence
- Importance of control matrices and algorithms
- Current status of containment guides
- Methods of optimising confidence towards worker safety
- Future of containment designs
Mr Peter Marshall, Associate Engineering Director, AstraZeneca
Mr Nigel Saunders, Technical Engineer - SME Containment, GSK
Dr Thomas Adam, Head of Global Quality Assurance Chemical APIs, Bayer

Internal procedure guide in handling high potent compounds
- Bayer quality organisation guidelines
- Internal procedures to minimise the risk of handling HPAPIs to workers
- Deciding the correct control based on a correctly identified hazard
Dr Thomas Adam, Head of Global Quality Assurance Chemical APIs, Bayer

Development and manufacture of HPAPI products through the clinical phases from molecule to market
- How HPAPIs can be developed into suitable drug dosage forms
- Strategies to adhere to the highest quality standards
- Complexities at each stage of the development cycle from FiM studies to global supply
Mr David O’Connell, Director Scientific Affairs, PCI Pharma Services

DEEP DIVE – CASE STUDY
Risk assessment of highly potent APIs cross-contamination and transportation parameters
- Guidelines regarding quality risk management
- Case study 1: technical aspects and complexity in cross contamination risk analysis
- Case study 2: temperature deviation during transportation
Dr Ildikó Ziegler, Distinguished Validation Expert, Gedeon Richter

Design and innovation of a new compound facility
- Reconstruction guidelines for adapting existing facilities to meet the needs of HPAPIs
- Ensuring facility reconstruction meets GMPs
- Additional assets required for HPAPI adaptation
- Designing controls and training to address worker safety
Dr Jack Brown, Senior Principal Scientist, Boehringer Ingelheim

View the programme at http://www.highlypotentapi.com

Registrations made before or on January 31st will include a £400 discount of the standard price.

Conference: 13th and 14th May 2019
Post-conference workshop: 15th May 2019
Holiday Inn Kensington Forum, London, UK

Conference organisers

SMi Group Ltd
India House, 35 Curlew Street
London
SE1 2ND
United Kingdom

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Latest Techniques in HPAPI Facility Design here

News-ID: 1549710 • Views: 360

More Releases from SMi Group Ltd

Maritime Safety Briefings to Look Forward to at Defence Safety 2020
Defence Safety 2020 will provide a comprehensive overview of safety within the military, aiming to review the safe delivery of defence capabilities, and the parts that operational users, equipment, and service delivery organisations, as well as research and development play. Once again supported by the UK MoD Defence Safety Authority, the event will feature a diverse, international speaker line-up of military and industry experts, who will explore the latest updates on
British Army to discuss RTR Developments at Future Armoured Vehicles Weapon Syst …
SMi Reports: Captain Tom Quant from the British Army confirmed to present at Future Armoured Vehicles Systems 2020 The 4th annual Future Armoured Vehicles Weapon Systems 2020 will be held on the 3rd and 4th June 2020 in London, UK, where delegates will have the opportunity to hear updates on the latest weapon systems and munitions developments. This year's conference will host experts from the most forward-thinking nations who will provide detailed
Worldwide Collaboration is Key to the Future of Water Supply
The World Water Innovation Fund initiative which was set up by a number of international water companies to work collaboratively to share experiences and ideas, is recognised as one of the key drivers to ensure that everyone has access to clean drinking water for years to come. It provides an opportunity for these organisations to utilise their time and funding to test new technologies, research, trial new ideas and share
HPAPI 2020 conference to discuss containment solutions and ADC developments
On the 11th - 12th May 2020, industry professionals will convene in London to discuss the challenges of the HPAPI industry at the Highly Potent Active Pharmaceutical Ingredients conference. The global market for Highly Potent Active Pharmaceutical Ingredients has experienced an increased growth, resulting from its major use in oncology for cancer treatment - more often in the form of antibody drug conjugates (ADC). With this in mind, one of the

All 5 Releases


More Releases for HPAPI

High Potency Active Pharmaceutical Ingredients (HPAPI) Market Outlook To 2024
High Potency Active Pharmaceutical Ingredients (HPAPI) Market Outlook To 2024: Key Product Categories (Synthetic, Biotech), Type (Innovative, Generic), End-Use (Oncology, Hormonal, Glaucoma), Regional Segmentation, Competitive Dynamics, Pricing Analysis (OPP, IPP, RAP) And Segment Forecast The global high potency active pharmaceutical Ingredients (HPAPI) Market was valued at $14.36 billion in 2016 and is forecast to grow at a steady CAGR of 8.4% between 2017 and 2024, culminating in 2024 global revenue of
Global High Performance Active Pharmaceutical Ingredients (HPAPI) Market Researc …
This report studies the global High Performance Active Pharmaceutical Ingredients (HPAPI) market status and forecast, categorizes the global High Performance Active Pharmaceutical Ingredients (HPAPI) market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Bristol-Myers Squibb Novartis Sanofi Aventis Pfizer Lonza Novasep Hospira
HPAPI 2019 Conference: Exclusive Interview Released with AstraZeneca
Peter Marshall from AstraZeneca will be speaking at SMi’s 3rd Annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) Conference which will take place in London on 13th-14th May. He will be discussing the latest developments in the industry with a specific focus on the principles of pharmaceutical containment in isolator design. Ahead of the conference, SMi had interviewed him where he gave a taster of what he will be discussing. Peter said: “The
HPAPI (High Potency Active Pharmaceutical Ingredients) Market Report 2018: Segme …
Global HPAPI (High Potency Active Pharmaceutical Ingredients) market research report provides company profile for Lonza, Novasep, Thermofisher Scientific, Alkermes, Cambrex, Dishman, Dr. Reddy’S and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report
SMi’s HPAPI 2018 Conference: Exclusive Interview Released with HPAPI Project S …
SMi are delighted to have our Chairman, Speaker and Workshop Host, Justin Mason-Home, Director, HPAPI Project Services Limited, onto the speaker panel for HPAPI 2018! About Justin: Justin Mason-Home is an organic chemist with extensive health, safety, environmental and chemical engineering experience in senior technical, legal and commercial aspects of the pharmaceutical, biochemical, chemical and other industries. He has held senior positions and worked globally in potent biopharmaceutical occupational health and safety
Exclusive Interview Released with HPAPI Project Services
SMi are delighted to have our Chairman, Speaker and Workshop Host, Justin Mason-Home, Director, HPAPI Project Services Limited, onto the speaker panel for HPAPI 2018! About Justin: Justin Mason-Home is an organic chemist with extensive health, safety, environmental and chemical engineering experience in senior technical, legal and commercial aspects of the pharmaceutical, biochemical, chemical and other industries. He has held senior positions and worked globally in potent biopharmaceutical occupational health and safety